Download PDF
Thromb Haemost 1997; 77(02): 278-282
DOI: 10.1055/s-0038-1655953
Original Article
Schattauer GmbH Stuttgart

Massive Fibrin Formation with Consecutive Impairment of Fibrinolysis in Patients with Out-of-Hospital Cardiac Arrest

Satoshi Gando
The Department of Emergency and Critical Care Medicine, Sapporo City General Hospital, Sapporo, Japan
,
Takashi Kameue
The Department of Emergency and Critical Care Medicine, Sapporo City General Hospital, Sapporo, Japan
,
Satoshi Nanzaki
The Department of Emergency and Critical Care Medicine, Sapporo City General Hospital, Sapporo, Japan
,
Yoshimi Nakanishi
The Department of Emergency and Critical Care Medicine, Sapporo City General Hospital, Sapporo, Japan
› Author Affiliations
Further Information

Publication History

Received 30 April 1996

Accepted after revision 28 October 1996

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Hypoxia and ischaemia influence blood coagulation and fibrinolysis. This study has been made to determine whether human cardiopulmonary arrest causes fibrin formation and reduction of fibrinolysis. Serial levels of fibrinopeptide A (FPA), fibrinopeptide Bβ15-42 (FPBβ15-42), D-dimer, tissue plasminogen activator antigen concentration (t-PA antigen), t-PA activity, plasminogen activator inhibitor-1 antigen concentration (PAI-1 antigen), and PAI-1 activity were determined in 63 patients with out-of-hospital cardiopulmonary arrest. In the resuscitated patients, the markedly elevated FPA (194.8 ± 54.2 ng/ml) at the beginning of cardiopulmonary resuscitation (CPR) significantly decreased to 32.4 ± 9.1 ng/ml at 24 h after admission (p <0.01), however, this was still about 20 times that of the normal controls. FPBβ15-42 and D-dimer increased from the start of CPR to 60 min (189.3 ± 97.4 ng/ml; p <0.01 and 7726 ± 3556 ng/ml; p <0.001, respectively), and then decreased at 24 h after arrival at the Emergency Department (40.4 ±11.1 ng/ml and 5434 ± 1049 ng/ml, respectively). At 30 min after arrival, FPA and FPBβ15-42 significantly differed between the resuscitated patients and the patients who died (p <0.001 and P <0.05, respectively). Although t-PA antigen and t-PA activity was elevated at the time of arrival, 24 h thereafter, no t-PA activity was detected. At 24 h after admission, PAI-1 antigen and PAI-1 activity were significantly increased (472.2 ± 145.5 ng/ml; p <0.001 and 103.6 ± 36.1 IU/ml; p <0.001, respectively). In conclusion, during and after CPR in patients with out-of-hospital cardiac arrest, massive fibrin generation with consecutive impairment of fibrinolysis were observed. These fibrin-mediated events may have some role in the derangement of vital organ function after cardiac arrest.

 

  • References

  • 1 Safer P, Bircher NG. Prolonged life support. In: Cardiopulmonary and Cerebral Resuscitation. Basic and Advanced Cardiac and Trauma Life Support Safer P, Bircher NG. eds 03. W.B. Saunders Company; Philadelphia: 1988. pp 229-278
    Google Scholar
  • 2 Abramson NS. Brain resuscitation. In: Emergency Medicine. Concepts and Clinical Practice Rosen P, Barkin RM, Braen GR, Dailey RH, Hedges JR, Hockberger RS, Levy RC, Marx JA, Smith M. eds. 03. Mosby Year Book; St. Louis: 1992. pp. 173-186
    Google Scholar
  • 3 Rogers MC, Kirsch JR. Concepts in emergency and critical care. Current concepts in brain resuscitation. JAMA 1989; 261: 3143-3147
    CrossrefPubMedGoogle Scholar
  • 4 Mangum M, Venable RH, Boatwright JD, Cocke TB. Hypoxia: A stimulus for tissue plasminogen activator release in humans?. Aviat Space Environ Med 1987; 58: 1093-1096
    PubMedGoogle Scholar
  • 5 Bärtsch P, Haeberli A, Hauser K, Gubser A, Straub PW. Fibrinogenolysis in the absence of fibrin formation in severe hypobaric hypoxia. Aviat Space Environ Med 1988; 59: 428-432
    PubMedGoogle Scholar
  • 6 Gertler JP, Abbott WM. Current research review. Prothrombotic and fibrinolytic function of normal and perturbed endothelium. J Surg Res 1992; 52: 89-95
    CrossrefPubMedGoogle Scholar
  • 7 Risberg B, Stenberg B. Modulation of tissue fibrinolysis from hypoxia and hyperoxia. Thromb Res 1985; 38: 129-136
    CrossrefPubMedGoogle Scholar
  • 8 Wojta J, Jones RL, Binder BR, Hoover RL. Reduction in PO2decreases the fibrinolytic potential of cultured bovine endothelial cells derived from pulmonary arteries and lung microvasculature. Blood 1988; 71: 1703-1706
    CrossrefPubMedGoogle Scholar
  • 9 Stegner M, Petemel P, Chen JP. Acute hypoxemia dose not increase fibrinolytic activity in man. Thromb Res 1987; 45: 333-341
    CrossrefPubMedGoogle Scholar
  • 10 Mehta B, Briggs DK, Sommers SC, Karpatkin M. Disseminated intravascular coagulation following cardiac arrest: a study of 15 patients. Am J Med Sci 1972; 264: 353-363
    CrossrefPubMedGoogle Scholar
  • 11 Fisher M, Francis R. Altered coagulation in cerebral ischaemia. Platelet, thrombin, and plasmin activity. Arch Neurol 1990; 47: 1075-1079
    CrossrefPubMedGoogle Scholar
  • 12 Thomas WS, Mori E, Copeland BR, Yu J-Q, Morrissey JH, del ZoppoGJ. Tissue factor contributes to microvascular defects after focal cerebral ischaemia. Stroke 1993; 24: 847-854
    CrossrefPubMedGoogle Scholar
  • 13 Okada Y, Copeland BR, Fitridge R, Koziol JA, del ZoppoGJ. Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischaemia and reperfusion. Stroke 1994; 25: 1847-1854
    CrossrefPubMedGoogle Scholar
  • 14 Gallino A, Haeberli A, Hess T, Mombelli G, Straub PW. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: Effects of intravenous and subcutaneous low-dose heparin. Am Heart J 1986; 112: 285-290
    CrossrefPubMedGoogle Scholar
  • 15 Rapold HJ, de BonoD, Arnold AER, Amout J, DeCock F, Collen D, Verstraete M. European Cooperative Study Group. Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant he parin coronaryartery patency and recurrent ischaemia Circulation 1992; 85: 928-934
    CrossrefPubMedGoogle Scholar
  • 16 Munkvad S, Gram JJ, Kluft C. Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium. J Intern Med 1990; 228: 361-366
    CrossrefPubMedGoogle Scholar
  • 17 Eneström S, Druid H, Rammer L. Fibrin deposition in the kidney in post-ischemic renal damage. Br J Exp Pathol 1988; 69: 387-394
    PubMedGoogle Scholar
  • 18 Druid H, Rammer L. Protective effect on postaeschemic renal edema by anticoagulation. Nephron 1992; 60: 319-323
    CrossrefPubMedGoogle Scholar
  • 19 American Heart Association. Standards and Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC). JAMA 1986; 255: 2905-2989
    CrossrefPubMedGoogle Scholar
  • 20 Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett P, Becker L, Bossaert L, Delooz H, Dick W, Eisenberg M, Evans T, Holmberg s, Kerber R, Mullie A, Omato JP, Sandoe E, Skulberg A, Tunstall-Pedoe H, Swanson R, Theis WH. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: The Utstein style. Ann Emerg Med 1991; 20: 861-874
    CrossrefPubMedGoogle Scholar
  • 21 Stullken EH, Sokoll MD. The effects of heparin on recovery from ischemic brain injuries in cats. Anesth Analg 1976; 55: 683-687
    PubMedGoogle Scholar
  • 22 Safer P. Effects of the postresuscitation syndrome on cerebral recovery from cardiac arrest. Crit Care Med 1985; 13: 932-935
    CrossrefPubMedGoogle Scholar
  • 23 Bottiger BW, Motsch J, Böhrer H, Böker T, Aulmann M, Nawroth PP, Martin E. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 1995; 92: 2572-2578
    CrossrefPubMedGoogle Scholar
  • 24 Ames III A, Wright RL, Kowada M, Thurston JM, Majno G, Cerebral II ischaemia. The no-reflow phenomenon. Am J Pathol 1968; 52: 437-453
    PubMedGoogle Scholar
  • 25 Takemoto Y, Tanaka S, Tanabe J, Nakamura Y, Kohama A, Shibata S. Studies on the effects of primary therapy for DIC following circulatory arrest. Am J Hematol 1986; 21: 377-382
    CrossrefPubMedGoogle Scholar
  • 26 delZoppo GJ, Yu J-Q, Copeland BR, Thomas WS, Scneiderman J, Morrissey J. Tissue factor location in non-human primate cerebral tissue. Thromb Haemost 1992; 68: 642-647
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Yamamoto T, Hirato T, Inagaki M, Kikumoto R, Tamano Y, Okamoto S. Effect of MCI-9038, a selective thrombin inhibitor on cerebral microcirculation after cerebral ischaemia in rats. Thromb Haemost 1987; 58: 108-112
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Bylock A, Stenberg B, Risberg B. Endothelial surface ultrastructure following hypoxia and hyperoxia. Artery 1986; 13: 286-306
    PubMedGoogle Scholar
  • 29 Hansen PR. Role of neutrophils in myocardial ischaemia and reperfusion. Circulation 1995; 91: 1872-1885
    CrossrefPubMedGoogle Scholar
  • 30 Hirsh JH, Salzman EW, Marder VJ, Colman RW. Overview of the thrombotic process and its therapy. In: Hemostasis and Thrombosis. Basic principal and clinical practice Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. 03. J. B. Lippincott; Philadelphia: 1994. pp 1151-1163
    Google Scholar
  • 31 Wortsman J, Frank S, Cryer PE. Adrenomedullary response to maximal stress in humans. Am J Med 1984; 77: 779-784
    CrossrefPubMedGoogle Scholar
  • 32 Tappy L, Hauert J, Bachmann F. Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system. Thromb Res 1984; 33: 117-124
    CrossrefPubMedGoogle Scholar
  • 33 Schleef RR, Loskutoff DJ, Poder TJ. Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells. J Cell Biol 1991; 113: 1413-1423
    CrossrefPubMedGoogle Scholar
  • 34 Gelehrter TD, Sznycer-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest 1986; 77: 165-169
    CrossrefPubMedGoogle Scholar
  • 35 Fujii S, Lucore CL, Hopkins WE, Billadello JJ, Sobel BE. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in hepatic and endothelial cells. Thromb Haemost 1990; 64: 412-419
    Article in Thieme ConnectPubMedGoogle Scholar